Objective To assess the current literature on the impact of rheumatoid arthritis (RA)
treatments on the humoral response to pneumococcal and influenza vaccines. Methods We …

Aim To present a systematic literature review (SLR) on efficacy, immunogenicity and safety
of vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic.
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …

Objective To provide evidence‐based recommendations on the use of vaccinations in
children and adults with rheumatic and musculoskeletal diseases (RMDs). Methods This …

Objective To investigate the humoral and cellular immune response to messenger RNA
(mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases …

Background Patients on therapeutic immunosuppressants for immune-mediated
inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to …

To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Secondary hypogammaglobulinemia (SHG) is characterized by reduced immunoglobulin
levels due to acquired causes of decreased antibody production or increased antibody loss …

Objective To determine whether a 2-week methotrexate (MTX) discontinuation after
vaccination improves the efficacy of seasonal influenza vaccination in patients with …

Objective To evaluate the effect on immunogenicity and safety of 2-week methotrexate
(MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine versus MTX …